BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20202928)

  • 1. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.
    Krishnan E
    Rheumatology (Oxford); 2010 Jul; 49(7):1229-38. PubMed ID: 20202928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term remission from gout associated with fenofibrate therapy.
    Hepburn AL; Kaye SA; Feher MD
    Clin Rheumatol; 2003 Feb; 22(1):73-6. PubMed ID: 12605325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
    Dalbeth N; Merriman T
    Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there anything good in uric acid?
    Alvarez-Lario B; Macarrón-Vicente J
    QJM; 2011 Dec; 104(12):1015-24. PubMed ID: 21908382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal regulation of plasma total antioxidant capacity.
    Kirschbaum B
    Med Hypotheses; 2001 Jun; 56(6):625-9. PubMed ID: 11399110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
    Keenan RT; Pillinger MH
    Bull NYU Hosp Jt Dis; 2009; 67(3):285-90. PubMed ID: 19852752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do I need to know about gout?
    Becker MA; Ruoff GE
    J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradoxical relationship between serum uric acid and cardiovascular disease.
    Lippi G; Montagnana M; Franchini M; Favaloro EJ; Targher G
    Clin Chim Acta; 2008 Jun; 392(1-2):1-7. PubMed ID: 18348869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout: epitome of painful arthritis.
    VanItallie TB
    Metabolism; 2010 Oct; 59 Suppl 1():S32-6. PubMed ID: 20837191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
    Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
    J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia, gout and the metabolic syndrome.
    Puig JG; Martínez MA
    Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future therapeutic options for the management of gout.
    Whelton A
    Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
    Glasnović M
    Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperuricemia and atherosclerosis].
    Nishioka K; Iwatani M
    Nihon Rinsho; 1993 Aug; 51(8):2177-81. PubMed ID: 8411689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis, clinical findings and management of acute and chronic gout.
    Corrado A; D'Onofrio F; Santoro N; Melillo N; Cantatore FP
    Minerva Med; 2006 Dec; 97(6):495-509. PubMed ID: 17213786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.